Cargando…
Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
Age is among the most prominent risk factors for developing severe COVID-19 disease, and therefore older adults are a major target group for vaccination against SARS-CoV-2. This review focusses on age-associated aspects of COVID-19 vaccines and vaccination strategies, and summarizes data on immunoge...
Autor principal: | Weinberger, Birgit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704374/ https://www.ncbi.nlm.nih.gov/pubmed/34960181 http://dx.doi.org/10.3390/vaccines9121435 |
Ejemplares similares
-
Nucleic Acid Vaccines against SARS-CoV-2
por: Liu, Ying, et al.
Publicado: (2022) -
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021) -
Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
por: Tiboni, Mattia, et al.
Publicado: (2021) -
The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023) -
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)